Skip to main content
The Name of the #1 Stock to Trade in 2021
Expert Jeff Clark is releasing his #1 stock to trade in 2021.

Since he started recommending this stock, you could have used it for gains as high as 269% and even 273%... in as little as 8 days.
Click here now and get its name.

BMRN Insider Trading (BioMarin Pharmaceutical)

Insider Ownership Percentage: 2.15%
Insider Buying (Last 12 Months): $1,001,728.00
Insider Selling (Last 12 Months): $30,851,118.91

BioMarin Pharmaceutical Insider Trading History Chart

BioMarin Pharmaceutical Share Price & Price History

▼ -0.84 (-1.07%)
As of 05/7/2021 01:00 AM ET
Days: 30 | 90 | 365
Former Congressman warns something BIG is coming
There’s an important message that’s lost on anyone listening to the mainstream narrative right now. But serious signs of trouble are already starting to appear. And the long-term effects will be devastating. Find out in this new video what’s really going on. Then protect yourself and your family from what’s right around the corner.
Click Here To See Those Steps

BioMarin Pharmaceutical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/6/2021Richard A MeierDirectorSell5,068$78.38$397,229.8499,340View SEC Filing Icon  
5/3/2021George Eric DavisEVPSell4,673$78.30$365,895.9068,781View SEC Filing Icon  
4/23/2021Jean Jacques BienaimeCEOSell10,000$79.34$793,400.00312,498View SEC Filing Icon  
4/19/2021George Eric DavisEVPSell2,709$79.58$215,582.2271,149View SEC Filing Icon  
4/8/2021Jeffrey Robert AjerEVPSell1,537$78.81$121,130.9758,250View SEC Filing Icon  
4/1/2021Brian MuellerCFOSell5,692$76.30$434,299.6031,016View SEC Filing Icon  
3/24/2021Jeffrey Robert AjerEVPSell1,181$76.30$90,110.3061,439View SEC Filing Icon  
3/18/2021Jeffrey Robert AjerEVPSell1,308$77.99$102,010.9264,133View SEC Filing Icon  
3/11/2021Jean Jacques BienaimeCEOSell7,000$77.68$543,760.00295,652View SEC Filing Icon  
3/5/2021Michael G GreyDirectorSell5,000$76.28$381,400.0047,840View SEC Filing Icon  
2/19/2021Jean Jacques BienaimeCEOSell7,000$83.58$585,060.00302,552View SEC Filing Icon  
2/17/2021Jean Jacques BienaimeCEOSell8,000$84.54$676,320.00303,552View SEC Filing Icon  
1/29/2021Jean Jacques BienaimeCEOSell8,334$82.67$688,971.78303,885View SEC Filing Icon  
1/27/2021Jean Jacques BienaimeCEOSell8,333$85.49$712,388.17303,885View SEC Filing Icon  
12/28/2020Jean Jacques BienaimeCEOSell1,500$88.77$133,155.00297,052View SEC Filing Icon  
10/14/2020Jeffrey Robert AjerEVPSell2,121$79.91$169,489.1161,281View SEC Filing Icon  
8/31/2020David E I PyottDirectorBuy12,800$78.26$1,001,728.0029,840View SEC Filing Icon  
8/3/2020Michael G GreyDirectorSell2,500$120.35$300,875.0045,340View SEC Filing Icon  
7/20/2020Henry J FuchsInsiderSell126,389$130.00$16,430,570.00104,245View SEC Filing Icon  
7/13/2020Henry J FuchsInsiderSell23,011$130.00$2,991,430.00102,995View SEC Filing Icon  
6/26/2020Willard H DereDirectorSell4,430$123.61$547,592.3013,290View SEC Filing Icon  
6/19/2020Jeffrey Robert AjerEVPSell15,000$124.00$1,860,000.0063,402View SEC Filing Icon  
6/5/2020V Bryan LawlisDirectorSell4,430$107.46$476,047.8018,850View SEC Filing Icon  
5/8/2020Jean Jacques BienaimeCEOSell20,000$91.72$1,834,400.00318,552View SEC Filing Icon  
5/4/2020Jean Jacques BienaimeCEOSell5,000$88.00$440,000.00298,552View SEC Filing Icon  
5/1/2020George Eric DavisEVPSell12,504$89.38$1,117,607.5278,181View SEC Filing Icon  
5/1/2020Jean Jacques BienaimeCEOSell4,000$89.38$357,520.00298,552View SEC Filing Icon  
4/28/2020Jean Jacques BienaimeCEOSell20,000$97.58$1,951,600.00318,213View SEC Filing Icon  
4/24/2020Henry J FuchsInsiderSell20,000$95.88$1,917,600.00109,014View SEC Filing Icon  
4/20/2020Henry J FuchsInsiderSell17,213$90.00$1,549,170.00122,656View SEC Filing Icon  
4/9/2020Jean Jacques BienaimeCEOSell10,000$79.06$790,600.00308,213View SEC Filing Icon  
4/8/2020Jeffrey Robert AjerEVPSell2,407$79.98$192,511.8663,064View SEC Filing Icon  
4/1/2020Jeffrey Robert AjerEVPSell1,537$82.00$126,034.0065,471View SEC Filing Icon  
3/24/2020Jeffrey Robert AjerEVPSell2,041$74.36$151,768.7668,626View SEC Filing Icon  
3/17/2020V Bryan LawlisDirectorSell3,750$75.39$282,712.5018,980View SEC Filing Icon  
3/9/2020Jean Jacques BienaimeCEOSell10,000$89.52$895,200.00296,443View SEC Filing Icon  
1/14/2020Jean Jacques BienaimeCEOSell8,000$87.95$703,600.00335,530View SEC Filing Icon  
1/7/2020Jean Jacques BienaimeCEOSell3,000$84.46$253,380.00330,530View SEC Filing Icon  
12/27/2019Jean Jacques BienaimeCEOSell5,000$86.16$430,800.00View SEC Filing Icon  
12/17/2019V Bryan LawlisDirectorSell3,750$83.36$312,600.0027,340View SEC Filing Icon  
11/26/2019George Eric DavisEVPSell3,190$79.66$254,115.4068,709View SEC Filing Icon  
11/22/2019Jean Jacques BienaimeCEOSell10,000$77.60$776,000.00327,070View SEC Filing Icon  
10/25/2019Jean Jacques BienaimeCEOSell5,000$69.55$347,750.00332,520View SEC Filing Icon  
9/17/2019V Bryan LawlisDirectorSell3,750$74.47$279,262.5027,340View SEC Filing Icon  
6/17/2019V Bryan LawlisDirectorSell3,750$81.08$304,050.0027,340View SEC Filing Icon  
5/10/2019Jean Jacques BienaimeCEOSell10,000$82.52$825,200.00336,520View SEC Filing Icon  
5/8/2019Jean Jacques BienaimeCEOSell4,000$82.16$328,640.00326,520View SEC Filing Icon  
4/26/2019Jean Jacques BienaimeCEOSell3,000$82.88$248,640.00329,211View SEC Filing Icon  
4/12/2019Jean Jacques BienaimeCEOSell4,000$89.12$356,480.00325,211View SEC Filing Icon  
4/8/2019Jean Jacques BienaimeCEOSell3,000$91.87$275,610.00327,211View SEC Filing Icon  
4/5/2019Brian MuellerSVPSell2,953$94.00$277,582.0013,660View SEC Filing Icon  
4/5/2019Jean Jacques BienaimeCEOSell3,000$93.37$280,110.00327,211View SEC Filing Icon  
4/1/2019Daniel K SpiegelmanCFOSell13,473$89.00$1,199,097.0047,510View SEC Filing Icon  
3/27/2019Daniel K SpiegelmanCFOSell100$90.00$9,000.0060,983View SEC Filing Icon  
3/27/2019V Bryan LawlisDirectorSell2,150$89.76$192,984.0021,310View SEC Filing Icon  
3/25/2019George Eric DavisEVPSell3,363$87.86$295,473.1875,253View SEC Filing Icon  
3/25/2019Henry J FuchsInsiderSell5,932$87.86$521,185.52130,468View SEC Filing Icon  
3/25/2019Jean Jacques BienaimeCEOSell4,000$87.86$351,440.00323,211View SEC Filing Icon  
3/21/2019Jeffrey Robert AjerEVPSell4,519$89.98$406,619.6256,659View SEC Filing Icon  
3/19/2019Jeffrey Robert AjerEVPSell3,728$93.07$346,964.9659,248View SEC Filing Icon  
3/18/2019Henry J FuchsInsiderSell9,597$94.09$902,981.73133,061View SEC Filing Icon  
3/15/2019Jean Jacques BienaimeCEOSell4,000$94.40$377,600.00300,558View SEC Filing Icon  
3/12/2019Jean Jacques BienaimeCEOSell9,000$90.06$810,540.00333,701View SEC Filing Icon  
3/7/2019Jean Jacques BienaimeCEOSell4,000$90.78$363,120.00332,701View SEC Filing Icon  
3/4/2019Henry J FuchsInsiderSell2,196$95.00$208,620.00142,504View SEC Filing Icon  
2/27/2019Jean Jacques BienaimeCEOSell4,000$91.78$367,120.00292,290View SEC Filing Icon  
2/21/2019Jean Jacques BienaimeCEOSell3,000$90.12$270,360.00291,290View SEC Filing Icon  
2/14/2019Jean Jacques BienaimeCEOSell4,000$95.20$380,800.00292,290View SEC Filing Icon  
2/5/2019Jean Jacques BienaimeCEOSell4,000$98.63$394,520.00292,290View SEC Filing Icon  
1/22/2019Jean Jacques BienaimeCEOSell3,000$96.82$290,460.00291,290View SEC Filing Icon  
1/14/2019Jean Jacques BienaimeCEOSell4,000$93.79$375,160.00292,290View SEC Filing Icon  
1/10/2019Jean Jacques BienaimeCEOSell3,000$90.55$271,650.00291,290View SEC Filing Icon  
1/7/2019Jean Jacques BienaimeCEOSell3,000$87.58$262,740.00291,290View SEC Filing Icon  
12/28/2018Jean Jacques BienaimeCEOSell3,000$84.04$252,120.00View SEC Filing Icon  
12/28/2018Jean Jacques BienaimeCEOSell3,000$84.04$252,120.00291,290View SEC Filing Icon  
12/27/2018V Bryan LawlisDirectorSell2,150$82.53$177,439.5021,310View SEC Filing Icon  
12/26/2018Jean Jacques BienaimeCEOSell4,000$80.50$322,000.00292,290View SEC Filing Icon  
12/14/2018Jean Jacques BienaimeCEOSell2,000$92.64$185,280.00290,290View SEC Filing Icon  
12/12/2018Jean Jacques BienaimeCEOSell2,000$93.12$186,240.00290,290View SEC Filing Icon  
11/14/2018Jeffrey Robert AjerEVPSell9,000$92.15$829,350.0058,135View SEC Filing Icon  
11/1/2018Jean Jacques BienaimeCEOSell4,000$92.55$370,200.00292,290View SEC Filing Icon  
10/3/2018Jean Jacques BienaimeCEOSell1,500$99.36$149,040.00287,790View SEC Filing Icon  
10/3/2018Jeffrey Robert AjerEVPSell1,000$98.98$98,980.0049,135View SEC Filing Icon  
9/27/2018V Bryan LawlisDirectorSell2,150$97.93$210,549.5021,310View SEC Filing Icon  
9/13/2018George Eric DavisEVPSell12,000$99.57$1,194,840.0074,950View SEC Filing Icon  
9/13/2018Richard A MeierDirectorSell3,000$99.24$297,720.0081,610View SEC Filing Icon  
9/5/2018Elaine J HeronDirectorSell1,000$96.94$96,940.0041,685View SEC Filing Icon  
9/4/2018Jean Jacques BienaimeCEOSell1,500$98.16$147,240.00286,790View SEC Filing Icon  
8/27/2018Henry J FuchsInsiderSell25,000$99.50$2,487,500.00142,667View SEC Filing Icon  
8/27/2018Richard A MeierDirectorSell2,000$100.12$200,240.0069,610View SEC Filing Icon  
8/24/2018Henry J FuchsInsiderSell12,500$99.00$1,237,500.00142,667View SEC Filing Icon  
8/21/2018Alan LewisDirectorSell4,200$100.09$420,378.0021,160View SEC Filing Icon  
8/7/2018Brian MuellerSVPSell2,500$104.50$261,250.0014,093View SEC Filing Icon  
8/7/2018Robert BaffiEVPSell5,173$105.00$543,165.0083,276View SEC Filing Icon  
7/23/2018Jean Jacques BienaimeCEOSell1,500$101.69$152,535.00286,790View SEC Filing Icon  
6/27/2018V Bryan LawlisDirectorSell2,150$93.52$201,068.0021,310View SEC Filing Icon  
6/22/2018Brian MuellerSVPSell3,145$99.50$312,927.5012,375View SEC Filing Icon  
6/22/2018Daniel K SpiegelmanCFOSell10,000$99.00$990,000.0051,542View SEC Filing Icon  
6/22/2018Robert BaffiEVPSell6,949$99.00$687,951.0090,225View SEC Filing Icon  
6/15/2018Brian MuellerSVPSell2,021$94.50$190,984.5013,029View SEC Filing Icon  
6/14/2018Henry J FuchsInsiderSell31,000$90.00$2,790,000.00157,167View SEC Filing Icon  
6/11/2018Jeffrey Robert AjerEVPSell1,436$90.31$129,685.1650,135View SEC Filing Icon  
5/17/2018Jean Jacques BienaimeCEOSell18,750$88.66$1,662,375.00309,350View SEC Filing Icon  
5/15/2018Jean Jacques BienaimeCEOSell37,500$88.75$3,328,125.00309,350View SEC Filing Icon  
5/11/2018Jean Jacques BienaimeCEOSell18,750$88.42$1,657,875.00View SEC Filing Icon  
5/10/2018Brian MuellerSVPSell2,450$89.50$219,275.0017,846View SEC Filing Icon  
5/7/2018Jeffrey Robert AjerEVPSell309$85.96$26,561.6453,223View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BioMarin Pharmaceutical (NASDAQ:BMRN)

97.65% of BioMarin Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioMarin Pharmaceutical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/7/2021Advisors Asset Management Inc.19,715$1.49M0.0%-7.8%0.011%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.3,876$0.29M0.0%-10.5%0.002%Search for SEC Filing on Google Icon
5/7/2021Cambridge Investment Research Advisors Inc.9,598$0.73M0.0%+76.3%0.005%Search for SEC Filing on Google Icon
5/7/2021Mariner LLC16,678$1.26M0.0%-34.1%0.009%Search for SEC Filing on Google Icon
5/7/2021Swiss National Bank697,232$52.65M0.0%+1.8%0.382%Search for SEC Filing on Google Icon
5/7/2021IndexIQ Advisors LLC2,889$0.22M0.0%+14.5%0.002%Search for SEC Filing on Google Icon
5/7/2021Clarus Group Inc.100,000$0.30M0.1%N/A0.055%Search for SEC Filing on Google Icon
5/7/2021The PNC Financial Services Group Inc.6,384$0.48M0.0%-26.0%0.003%Search for SEC Filing on Google Icon
5/7/2021Keybank National Association OH159,771$12.06M0.1%+144.0%0.087%Search for SEC Filing on Google Icon
5/7/2021Nippon Life Global Investors Americas Inc.221,860$16.75M0.9%+3.6%0.121%Search for SEC Filing on Google Icon
5/7/2021Altfest L J & Co. Inc.6,146$0.46M0.1%-7.5%0.003%Search for SEC Filing on Google Icon
5/7/2021Kistler Tiffany Companies LLC938$71K0.0%+16.1%0.001%Search for SEC Filing on Google Icon
5/7/2021Asahi Life Asset Management CO. LTD.3,950$0.30M0.0%N/A0.002%Search for SEC Filing on Google Icon
5/6/2021Arizona State Retirement System52,339$3.95M0.0%+0.6%0.029%Search for SEC Filing on Google Icon
5/6/2021Blueshift Asset Management LLC10,455$0.79M0.1%N/A0.006%Search for SEC Filing on Google Icon
5/6/2021Rhumbline Advisers192,187$14.51M0.0%-5.8%0.105%Search for SEC Filing on Google Icon
5/6/2021Quantitative Systematic Strategies LLC8,000$0.60M0.1%-35.3%0.004%Search for SEC Filing on Google Icon
5/6/2021Parnassus Investments CA2,684,874$202.74M0.5%+76.8%1.469%Search for SEC Filing on Google Icon
5/6/2021First National Trust Co55,302$4.18M0.3%N/A0.030%Search for SEC Filing on Google Icon
5/6/2021Alliancebernstein L.P.106,886$8.07M0.0%-74.4%0.058%Search for SEC Filing on Google Icon
5/6/2021Mitsubishi UFJ Kokusai Asset Management Co. Ltd.41,222$3.11M0.0%+10.2%0.023%Search for SEC Filing on Google Icon
5/6/2021Standard Life Aberdeen plc19,102$1.44M0.0%+2.2%0.010%Search for SEC Filing on Google Icon
5/6/2021M&T Bank Corp7,158$0.54M0.0%-23.7%0.004%Search for SEC Filing on Google Icon
5/5/2021Commerce Bank7,508$0.57M0.0%+7.4%0.004%Search for SEC Filing on Google Icon
5/5/2021TCW Group Inc.14,882$1.12M0.0%-97.8%0.008%Search for SEC Filing on Google Icon
5/5/2021IFM Investors Pty Ltd20,418$1.54M0.0%+17.3%0.011%Search for SEC Filing on Google Icon
5/5/2021Natixis Advisors L.P.20,064$1.52M0.0%-63.3%0.011%Search for SEC Filing on Google Icon
5/4/2021D.B. Root & Company LLC9,332$0.70M0.3%+33.4%0.005%Search for SEC Filing on Google Icon
5/4/2021Griffin Asset Management Inc.13,650$1.03M0.1%+21.0%0.008%Search for SEC Filing on Google Icon
5/4/2021Envestnet Asset Management Inc.159,427$12.04M0.0%+6.7%0.088%Search for SEC Filing on Google Icon
5/4/2021Commonwealth Equity Services LLC31,470$2.38M0.0%+9.1%0.017%Search for SEC Filing on Google Icon
5/4/2021Victory Capital Management Inc.717,582$54.19M0.1%-3.7%0.395%Search for SEC Filing on Google Icon
5/3/2021Great Lakes Advisors LLC85,692$6.47M0.1%+29.2%0.047%Search for SEC Filing on Google Icon
5/3/2021Treasurer of the State of North Carolina80,598$6.09M0.0%-0.3%0.044%Search for SEC Filing on Google Icon
5/3/2021B & T Capital Management DBA Alpha Capital Management18,260$1.38M0.4%+3.3%0.010%Search for SEC Filing on Google Icon
5/3/2021Daiwa Securities Group Inc.15,262$1.15M0.0%-8.6%0.008%Search for SEC Filing on Google Icon
5/3/2021Torray LLC16,057$1.21M0.2%-75.7%0.009%Search for SEC Filing on Google Icon
5/3/2021Zurcher Kantonalbank Zurich Cantonalbank 45,687$3.45M0.0%+19.2%0.025%Search for SEC Filing on Google Icon
5/3/2021Raymond James Trust N.A.3,424$0.26M0.0%-11.4%0.002%Search for SEC Filing on Google Icon
4/30/2021MUFG Americas Holdings Corp16,354$1.24M0.0%+72.5%0.009%Search for SEC Filing on Google Icon
4/30/2021Intrua Financial LLC2,650$0.21M0.1%N/A0.001%Search for SEC Filing on Google Icon
4/30/2021Wealthstreet Investment Advisors LLC26,318$1.99M0.2%-3.0%0.014%Search for SEC Filing on Google Icon
4/30/2021Exane Derivatives2,836$0.21M0.1%+52.6%0.002%Search for SEC Filing on Google Icon
4/30/2021IFP Advisors Inc2,316$0.18M0.0%+13.6%0.001%Search for SEC Filing on Google Icon
4/30/2021Stoneridge Investment Partners LLC5,866$0.44M0.2%N/A0.003%Search for SEC Filing on Google Icon
4/30/2021Sumitomo Mitsui Trust Holdings Inc.586,345$44.28M0.0%-5.0%0.322%Search for SEC Filing on Google Icon
4/30/2021BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp29,748$2.25M0.0%-2.7%0.016%Search for SEC Filing on Google Icon
4/29/2021Handelsbanken Fonder AB42,771$3.23M0.0%-1.0%0.024%Search for SEC Filing on Google Icon
4/28/2021NN Investment Partners Holdings N.V.35,624$2.69M0.0%+1.9%0.020%Search for SEC Filing on Google Icon
4/28/2021US Bancorp DE28,051$2.12M0.0%-48.6%0.015%Search for SEC Filing on Google Icon
4/28/2021DekaBank Deutsche Girozentrale273,732$20.49M0.1%+7.1%0.151%Search for SEC Filing on Google Icon
4/28/2021Comerica Bank26,409$2.08M0.0%-2.2%0.015%Search for SEC Filing on Google Icon
4/28/2021Manning & Napier Group LLC1,704,842$128.73M1.1%+57.4%0.938%Search for SEC Filing on Google Icon
4/28/2021Pegasus Asset Management Inc.22,310$1.69M0.9%+10.6%0.012%Search for SEC Filing on Google Icon
4/27/2021Janney Montgomery Scott LLC25,054$1.89M0.0%+4.9%0.014%Search for SEC Filing on Google Icon
4/27/2021State of New Jersey Common Pension Fund D112,119$8.47M0.0%-5.8%0.062%Search for SEC Filing on Google Icon
4/27/2021Crumly & Associates Inc.7,538$0.57M0.3%+84.2%0.004%Search for SEC Filing on Google Icon
4/26/2021Nisa Investment Advisors LLC20,630$1.56M0.0%+1.5%0.011%Search for SEC Filing on Google Icon
4/23/2021Fieldpoint Private Securities LLC1,895$0.14M0.0%-21.8%0.001%Search for SEC Filing on Google Icon
4/23/2021Robeco Institutional Asset Management B.V.13,325$1.01M0.0%-50.0%0.007%Search for SEC Filing on Google Icon
4/23/2021Strs Ohio24,912$1.88M0.0%-1.7%0.014%Search for SEC Filing on Google Icon
4/23/2021Arden Trust Co4,345$0.33M0.1%-14.6%0.002%Search for SEC Filing on Google Icon
4/22/2021Quattro Financial Advisors LLC12,000$0.96M0.2%N/A0.007%Search for SEC Filing on Google Icon
4/22/2021IBM Retirement Fund6,138$0.46M0.0%-8.2%0.003%Search for SEC Filing on Google Icon
4/22/2021Grandfield & Dodd LLC11,519$0.87M0.1%+2.5%0.006%Search for SEC Filing on Google Icon
4/21/2021Ingalls & Snyder LLC9,115$0.69M0.0%-14.6%0.005%Search for SEC Filing on Google Icon
4/21/2021BOKF NA14,214$1.07M0.0%+2.4%0.008%Search for SEC Filing on Google Icon
4/20/2021MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH5,203$0.39M0.0%N/A0.003%Search for SEC Filing on Google Icon
4/20/2021Exchange Traded Concepts LLC27,548$2.08M0.1%+66.6%0.015%Search for SEC Filing on Google Icon
4/19/2021Appleton Partners Inc. MA3,425$0.26M0.0%-27.0%0.002%Search for SEC Filing on Google Icon
4/19/2021CMH Wealth Management LLC33,992$2.57M1.0%+2.7%0.019%Search for SEC Filing on Google Icon
4/19/2021Guild Investment Management Inc.9,500$0.72M0.8%+6.6%0.005%Search for SEC Filing on Google Icon
4/16/2021Harbor Investment Advisory LLC2,412$0.18M0.0%+231.8%0.001%Search for SEC Filing on Google Icon
4/16/2021NEXT Financial Group Inc1,016$77K0.0%N/A0.001%Search for SEC Filing on Google Icon
4/16/2021Clarus Group Inc.100,000$0.30M0.2%N/A0.055%Search for SEC Filing on Google Icon
4/15/2021Rothschild Investment Corp IL14,798$1.12M0.1%+1.4%0.008%Search for SEC Filing on Google Icon
4/15/2021DnB Asset Management AS68,147$5.15M0.0%+16.6%0.037%Search for SEC Filing on Google Icon
4/15/2021Inspirion Wealth Advisors LLC5,054$0.38M0.1%N/A0.003%Search for SEC Filing on Google Icon
4/14/2021Gateway Investment Advisers LLC10,165$0.77M0.0%-1.6%0.006%Search for SEC Filing on Google Icon
4/14/2021Westside Investment Management Inc.3,870$6.33M0.0%+975.0%0.002%Search for SEC Filing on Google Icon
4/14/2021AdvisorNet Financial Inc5,726$0.43M0.0%+18.8%0.003%Search for SEC Filing on Google Icon
4/12/2021Valeo Financial Advisors LLC4,123$0.31M0.0%-3.5%0.002%Search for SEC Filing on Google Icon
4/9/2021Scout Investments Inc.480,377$36.27M0.5%+58.3%0.264%Search for SEC Filing on Google Icon
4/9/2021NuWave Investment Management LLC2,444$0.19M0.2%+550.0%0.001%Search for SEC Filing on Google Icon
4/5/2021Pacer Advisors Inc.1,019$77K0.0%-38.8%0.001%Search for SEC Filing on Google Icon
4/5/2021Fulton Bank N.A.3,839$0.29M0.0%+11.9%0.002%Search for SEC Filing on Google Icon
3/12/2021DekaBank Deutsche Girozentrale255,601$22.05M0.1%+1.4%0.141%Search for SEC Filing on Google Icon
3/8/2021B. Metzler seel. Sohn & Co. Holding AG25,387$2.21M0.0%N/A0.014%Search for SEC Filing on Google Icon
3/8/2021Teachers Retirement System of The State of Kentucky226,753$19.88M0.2%+23.9%0.125%Search for SEC Filing on Google Icon
3/8/2021Dimensional Fund Advisors LP428,296$37.56M0.0%+0.9%0.236%Search for SEC Filing on Google Icon
3/5/2021Jackson Square Capital LLC4,124$0.36M0.1%N/A0.002%Search for SEC Filing on Google Icon
3/4/2021Eaton Vance Management18,018$1.58M0.0%+3.2%0.010%Search for SEC Filing on Google Icon
3/2/2021Norges Bank1,449,496$127.11M0.0%N/A0.798%Search for SEC Filing on Google Icon
3/2/2021Capital Asset Advisory Services LLC2,116$0.19M0.0%N/A0.001%Search for SEC Filing on Google Icon
3/1/2021UBS Asset Management Americas Inc.2,462,265$215.92M0.1%+22.0%1.356%Search for SEC Filing on Google Icon
3/1/2021Healthcare of Ontario Pension Plan Trust Fund978$86K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/25/2021Dimensional Fund Advisors LP428,296$37.56M0.0%+0.9%0.236%Search for SEC Filing on Google Icon
2/24/2021Alyeska Investment Group L.P.51,888$4.55M0.1%-77.2%0.029%Search for SEC Filing on Google Icon
2/24/2021Bank Julius Baer & Co. Ltd Zurich14,049$1.23M0.0%+92.4%0.008%Search for SEC Filing on Google Icon
2/23/2021Principal Financial Group Inc.58,777$5.15M0.0%+27.4%0.032%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioMarin Pharmaceutical logo
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Aldurazyme to treat mucopolysaccharidosis I, a genetic disease; Brineura for the treatment of late infantile neuronal ceroid lipofuscinosis type 2, a form of Batten disease; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with mucopolysaccharidosis VI; Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme for adult patients with PKU; and Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis IV Type A, a lysosomal storage disorder. In addition, it develops valoctocogene roxaparvovec, an adeno associated virus vector, which is in Phase III clinical trial for the treatment of patients with severe hemophilia A; vosoritide that is in Phase III clinical trial for the treatment of achondroplasia, a form of disproportionate short stature in humans; BMN 307, an AAV5 mediated gene therapy, which is in phase 1/2 clinical trial to normalize blood Phe concentration levels in patients with PKU; BMN 331 for the treatment of hereditary angioedema; BMN 255 for the treatment of chronic renal disease; and BMN 351 for the treatment of Duchenne Muscular Dystrophy. The company has collaboration and license agreements with Sarepta Therapeutics, Asubio Pharma Co., Ltd., and DiNAQOR AG. The company serves specialty pharmacies, hospitals, and foreign government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. It has collaboration with Allen Institute. BioMarin Pharmaceutical Inc. was incorporated in 1996 and is headquartered in San Rafael, California.
Read More on BioMarin Pharmaceutical

Today's Range

Now: $77.77

50 Day Range

MA: $77.95

52 Week Range

Now: $77.77


628,868 shs

Average Volume

1,215,506 shs

Market Capitalization

$14.21 billion

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top insider shareholders include:
  1. Jean Jacques Bienaime (CEO)
  2. Henry J Fuchs (Insider)
  3. Richard A Meier (Director)
  4. George Eric Davis (EVP)
  5. Jeffrey Robert Ajer (EVP)
  6. Michael G Grey (Director)
  7. Brian Mueller (CFO)
  8. David E I Pyott (Director)
  9. V Bryan Lawlis (Director)
  10. Willard H Dere (Director)

Who are the major institutional investors of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top institutional investors include:
  1. Parnassus Investments CA — 1.47%
  2. Manning & Napier Group LLC — 0.94%
  3. Victory Capital Management Inc. — 0.39%
  4. Swiss National Bank — 0.38%
  5. Sumitomo Mitsui Trust Holdings Inc. — 0.32%
  6. Scout Investments Inc. — 0.26%

Which major investors are selling BioMarin Pharmaceutical stock?

During the previous quarter, BMRN stock was sold by these institutional investors:
  1. TCW Group Inc.
  2. Alliancebernstein L.P.
  3. Torray LLC
  4. Natixis Advisors L.P.
  5. Sumitomo Mitsui Trust Holdings Inc.
  6. Victory Capital Management Inc.
  7. US Bancorp DE
  8. Robeco Institutional Asset Management B.V.
During the previous year, company insiders that have sold BioMarin Pharmaceutical company stock include:
  1. Jean Jacques Bienaime (CEO)
  2. Henry J Fuchs (Insider)
  3. Richard A Meier (Director)
  4. George Eric Davis (EVP)
  5. Jeffrey Robert Ajer (EVP)
  6. Michael G Grey (Director)
  7. Brian Mueller (CFO)
  8. David E I Pyott (Director)
  9. V Bryan Lawlis (Director)

Which major investors are buying BioMarin Pharmaceutical stock?

During the last quarter, BMRN stock was bought by institutional investors including:
  1. Parnassus Investments CA
  2. Manning & Napier Group LLC
  3. Scout Investments Inc.
  4. Clarus Group Inc.
  5. Clarus Group Inc.
  6. Keybank National Association OH
  7. First National Trust Co
  8. Great Lakes Advisors LLC
Hidden $3 Stock Holds Tech World Hostage
Tech monsters like Apple, Amazon, Microsoft and many more can no longer avoid doing business with this one company that trades for only $3...All of them are held hostage by the CEO's brilliant business tactics. He intentionally set up his company's stock under a secret trade name...
Click here to see more.